Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
MASS · against 433 other Healthcare companies of similar size
Ranked #273 of 434 · scores higher than 11% of peers
Bars: peers in each 10-point band of the valuation score162 peers with a valuation score of 0–9, including MASS · Click a bar to see the companies
Mainly because of its earnings yield and EBITDA yield, which are weaker than most Healthcare peers.
| Metric | MASS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 420 reported | -8.8% | 0.1% | 29% | 30% | |
| EBITDA yieldHigher is better · 439 reported | -4.8% | 3.0% | 27% | 50% | |
| Free cash flow yieldHigher is better · 200 reported | 0.1% | -7.9% | 72% | 20% | |
| Book yieldHigher is better · 430 reported | 33.6% | 49.7% | 31% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 1 | 2.9B HKD (≈$365M) | 99 | 84 | |
| 1 | 89.9B JPY (≈$611M) | 99 | 68 | |
| 1 | 3.1B HKD (≈$396M) | 99 | 61 | |
| 1 | 6.50T IDR (≈$403M) | 99 | 69 | |
| 273 | 264M USD | 8 | 30 | |
| 273 | 255M USD | 8 | 38 | |
| 273 | 650M USD | 8 | 48 | |
| 273 | 264M USD | 8 | 24 | |
| 273 | 441M USD | 8 | 34 | |
| 273 | 366M CHF (≈$421M) | 8 | 23 | |
| 273 | 578M USD | 8 | 22 | |
| 273 | 299M USD | 8 | 38 | |
| 273 | 534M USD | 8 | 32 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score